Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX

$13.75 +1.70% at last close
Market Cap$4.39 billion
P/E Ratio36.18
Div Yield
Volume1.30M
52-Week Range $7.02$15.42

Key Stats

Today's Range
$13.55 $13.88
50-Day Range
$11.76 $13.92
52-Week Range
$7.02 $15.42
Volume
1.30 million shs
Average Volume
1.58 million shs
Market Cap
$4.39 billion
P/E Ratio
36.18
Dividend Yield

Valuation

P/E Ratio
36.18
Price / Book
-95.42
Price / Sales
1.44

Short Interest

Short Interest
2.40%
Days to Cover
3.54

Financials (TTM)

Revenue
$3.05 billion
Net Income
$181.31 million
Net Margin
5.95%
Return on Equity
-394.43%
Debt-to-Equity
-55.95

About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Sector
PHARMACEUTICAL PREPARATIONS
Employees
8,500
Exchange
XNAS
Listed
2018-05-07

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.